HHS Sends Warning Letters to Drug Manufacturers Regarding 340B Practices
May 19, 2021
The US Department of Health and Human Services’ Health Resources and Services Administration (HRSA) on Monday sent letters to six major drug manufacturers, warning them that they could face steep fines if they don't discount drug prices for pharmacies that contract with 340B providers.... Read More >>